CG Oncology CGON

CG Oncology, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$79.47-2.97%close on Nov. 20, 2026 · volume 1.7M · Yahoo Finance

Price, last 64 sessions

$60.00$70.00$80.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 20, 2026 · high $84.78 · low $59.85 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Nov. 18, 2026Arthur Kuan
Chief Executive Officer, director
Bought30,000$78.88$2.37 million
Nov. 18, 2026Isabel Kalofonos
Chief Commercial Officer · indirect
Bought3,751$79.76$299,161
Nov. 16, 2026Leonard E. Post
director
Sold
10b5-1 plan
1,000$92.00$92,000
Oct. 15, 2026Leonard E. Post
director
Sold
10b5-1 plan
1,000$62.07
$61.65-$62.48
$62,065
Sept. 15, 2026Leonard E. Post
director
Sold
10b5-1 plan
1,000$72.98$72,980
Aug. 14, 2026Leonard E. Post
director
Sold
10b5-1 plan
1,000$74.54$74,540

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 17 →
  • 4Nov. 18, 2026, 4:30 p.m. ETView on SEC.gov
  • 4Nov. 18, 2026, 4:30 p.m. ETView on SEC.gov
  • 4Nov. 17, 2026, 4:30 p.m. ETView on SEC.gov
  • 8-KNov. 16, 2026, 8:15 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedCG Oncology Reports Positive Phase 3 PIVOT-006 Topline Data: 68% Reduction in Recurrence Risk (HR 0.32) in Intermediate-Risk and HG Ta NMIBC; BCG-Unresponsive BLA Timing Pushed to March 2027

  • 10-QNov. 6, 2026, 8:45 a.m. ETView on SEC.gov
  • 8-KNov. 6, 2026, 8:30 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedCG Oncology Q3 2026 EPS of -$0.64 Beats -$0.81 Consensus; Revenue $1.6 Million Tops $0.5 Million Estimate

  • 4Oct. 19, 2026, 4:30 p.m. ETView on SEC.gov
  • 4Oct. 19, 2026, 4:30 p.m. ETView on SEC.gov